Letter to the Editor
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 7, 2025; 31(9): 100607
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100607
Figure 1
Figure 1 Strengths, weaknesses, opportunities, and threats of combination therapy for inflammatory bowel disease. SWOT: Strengths, weaknesses, opportunities, and threats.